C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)	Ewing sarcoma, Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Skin and Connective Tissue Diseases, Uveal Neoplasms, breast disorder, breast neoplasm, breast phyllodes tumor, connective tissue neoplasm, epithelial neoplasm, eye disorder, melanocytic neoplasm, melanoma, myomatous neoplasm, neoplasm, neuroblastoma, neuroendocrine neoplasm, neuroepithelial neoplasm, ocular cancer, osteosarcoma, phyllodes tumor, primitive neuroectodermal tumor, rhabdomyosarcoma, sarcoma, skin disorder, uveal disorder, uveal melanoma	Active, not recruiting	Phase 1	2026-07-06		NCT03635632

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Baylor College of Medicine	267
Cancer Prevention Research Institute of Texas	29
Center for Cell and Gene Therapy, Baylor College of Medicine	40
The Methodist Hospital Research Institute	124

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Houston Methodist Hospital	Houston	United States	260
Texas Children's Hospital	Houston	United States	187